O3.5A Phase Ib dose escalation study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.

Annals of Oncology

Mars 2015
O3.5A Phase Ib dose escalation study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.

Soria JC, Boni V, Gazzah A, Holgado E, Even C, Ould-Kaci M, Nazabadioko S, Xue W, Calvo E.